# Danaher to acquire GE Biopharma for $21.4 billion

Danaher Corporation announced a definitive agreement to acquire the Biopharma business of GE Life Sciences for approximately $21.4 billion in cash, with a net purchase price of about $20 billion after tax benefits.

- Type: Acquisition
- Announced: 2019-02-25
- Where: United States
- Value: $21.4B
- Status: announced
- Products: bioprocessing instruments, consumables, software
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [General Electric](https://endata.com/companies/1262.md)
- [General Electric](https://endata.com/companies/1262.md) (target)
- [Danaher](https://endata.com/companies/16260.md) (acquirer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/danaher-to-acquire-the-biopharma-business-of-general-electric-life-sciences-for-21-4-billion-300801090.html), 2019-02-25: "Danaher Corporation announced today that it has entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences for a cash purchase price of approximately $21.4 billion."
- [bloomberg.com](https://www.bloomberg.com/news/articles/2019-02-25/ge-surges-on-biopharma-unit-sale-to-danaher-for-21-4-billion), 2019-02-25: "Culp sees 'tide beginning to turn' as deal eases debt concerns"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.